New Anti-Cancer Drug Developed
ScienceDaily (May 22, 2012) — A team of University of Hawaii Cancer Center scientists led by James Turkson, Ph.D. have created a new type of anti-cancer drug named BP-1-102. The drug, which can be orally administered, targets a key protein that triggers the development of many types of cancer including lung, breast and skin cancers.
The development of BP-1-102 was guided by the research teams computer based molecular analysis of the cancer causing Stat 3 protein that causes cancer by promoting abnormal cell growth in otherwise healthy cells.
"The molecular structure of the hyperactive Stat3 protein basically resembles two cars that are joined together side-by-side," said Professor Turkson. "We then utilized a computer program that creates molecular models of potential drugs engaging in binding to the Stat3 protein to craft the BP-1-102 drug which literally pulls apart the Stat3 protein rendering it ineffective in causing cancer."
Read more here:
http://www.scienceda...20522115252.htm
New Anti-Cancer Drug Developed
Started by Dee, May 23 2012 08:50 AM
No replies to this topic
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users













